IPO registrations (S-1, F-1) · Registrants
GENITOPE CORP
- SEC CIK
- 1028358 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2003-08-06, last 2004-05-24; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2003-10-30
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 6900 DUMBARTON CIRCLE, Fremont, CA 94555-3651
- EIN
- 77-0436313
- EDGAR entity type
- operating
- Insiders and CEO pay
- GENITOPE CORP on the corporate pages
Offering terms
- Proposed price range
- $9.00–$13.00 per share (S-1/A filed 2003-10-28)
- Final price
- $9.00 per share, within the range (424B4 filed 2003-10-30, an initial public offering)
- Shares sold
- 3,700,000
- Gross proceeds
- $33,300,000 before underwriting discounts and any over-allotment option
- Lead underwriters
- WR Hambrecht+Co, LLC (2,220,000 shares)
- Syndicate
- Ziegel & Company; Murray & Co., Inc; Punk, Ziegel & Company, L.P (925,000); Brean Murray & Co., Inc (555,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: GENITOPE CORPORATION EXACT (EIN (EXACT))
- SEC filer: GENITOPE CORP EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2003-08-06 | S-1 | S-1 (registration) | GENITOPE CORP | 0000891618-03-004154 ↗ |
| 2003-08-26 | S-1/A | S-1/A (amendment) | GENITOPE CORP | 0000891618-03-004572 ↗ |
| 2003-09-11 | S-1/A | S-1/A (amendment) | GENITOPE CORP | 0000891618-03-004759 ↗ |
| 2003-10-09 | S-1/A | S-1/A (amendment) | GENITOPE CORP | 0000950149-03-002298 ↗ |
| 2003-10-28 | S-1/A | S-1/A (amendment) | GENITOPE CORP | 0000891618-03-005499 ↗ |
| 2003-10-30 | 424B4 | 424B4 (final prospectus) | GENITOPE CORP | 0000891618-03-005583 ↗ |
| 2004-05-05 | S-1 | S-1 (registration) | GENITOPE CORP | 0000891618-04-000962 ↗ |
| 2004-05-24 | S-1/A | S-1/A (amendment) | GENITOPE CORP | 0000950134-04-008038 ↗ |
| 2004-05-27 | S-1MEF | S-1MEF (added securities) | GENITOPE CORP | 0000950134-04-008155 ↗ |
| 2004-05-27 | 424B4 | 424B4 (final prospectus) | GENITOPE CORP | 0000950134-04-008185 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2003-10-28 | S-1/A | registration statement | $9.00–$13.00 | 4,600,000 | - | 2 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 2 | document ↗ | ||
| 2003-10-30 | 424B4 | final prospectus | $9.00 | 3,700,000 | $33,300,000 | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ENNIS GREGORY | Director | 5 | 2006–2007 | ||
| CHARPENTIER BONNIE | Officer | VP of Regulatory Affairs | 2 | 2006 | |
| MILLER CLAUDE | Officer | VP of Quality | 4 | 2006–2007 | |
| Buckley Michael J | Officer | VP of Manufacturing | 3 | 2006–2007 | |
| DENNEY DAN W JR | Director,Officer | CEO | 5 | 2006–2007 | |
| VUKO JOHN M | Officer | VP of Finance/CFO | 2 | 2006–2007 | |
| Rybak Mary Ellen | Officer | Chief Med. Officer & VP; CMO & VP Clinical Affairs | 3 | 2006–2007 | |
| DENNEY GORDON D | Director | 3 | 2006–2007 | ||
| FINNEY STANFORD C JR | Director | 5 | 2006–2007 | ||
| GOODE RONALD L | Director | 1 | 2006 | ||
| HASLER WILLIAM | Director | 2 | 2006–2007 | ||
| DeZao Thomas | Officer; Other | VP, Strategic Mktg & Sales | 4 | 2006–2008 | |
| Cardinal Investment Co Inc Profit Sharing Plan | TenPercentOwner | 13 | 2006–2007 | ||
| CPMG Inc | Other; TenPercentOwner | 19 | 2006–2008 | ||
| Rose Edward W. III | TenPercentOwner | 18 | 2006–2007 | ||
| McGaughy R Kent Jr | Director | 2 | 2007 | ||
| Overholtzer Gregory L | Officer | Controller/Principl Acctg Off | 1 | 2008 | |
| Powers Alan | TenPercentOwner | 1 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | GENITOPE CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Genitope Corporation | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | GENITOPE CORPORATION | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), CA first:
- SANGAMO THERAPEUTICS, INC CA
- ABGENIX INC CA
- COLLATERAL THERAPEUTICS INC CA
- Life Technologies Corp CA
- DRUGABUSE SCIENCES INC CA
- STRATAGENE CORP CA
- Cordex Pharma, Inc. CA
- COTHERIX INC CA
- Cardiff Oncology, Inc. CA
- Eiger BioPharmaceuticals, Inc. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health